SAB Biotherapeutics Announces Executive Leadership Change
SIOUX FALLS, S.D., Feb. 02, 2024 -- SAB Biotherapeutics, Inc. , , a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte...
Source: marketscreener.com